Japanese pharmaceutical company Astellas Pharma has adopted Acquia cloud site factory as the unified website platform for its local and global websites.
With digital technology agency partner CI&T Japan, Astellas has started using Acquia's cloud solutions and Drupal 8 to develop a standardised platform for the development, management and governance of multiple multilingual websites.
Astellas, which launched in Australia in 2011, says the unified website platform is a strategic initiative that makes it possible to further strengthen the publication of important information and governance “in a more timely, secure and stable manner, regardless of region or language”.
Shinya Suda, corporate vice-president of information systems at Astellas, says it plans to rebuild all corporate sites of the Astellas Group subsidiaries based on its unified platform.
“This project, supported by CI&T, will drive the ‘Astellas Way’ initiative by executing a digital governance strategy that focuses on key pillars including security, time to market, quality, standardisation, innovation, and user experience.
“By choosing Acquia Cloud Site Factory, we were able to build an IT infrastructure to optimise the system architecture and operation at the global level. We believe that by utilising this service, we were able to achieve the highest level of availability and safety that is essential for timely and appropriate information disclosure to our stakeholders.”
According to Yoshiyuki Ueda, business director of Japan at CI&T, as of now, Acquia cloud products together with Drupal 8 have become “the platform of choice for high-end digital transformation, as a leader in enterprise CMS in western countries”.
Darren Watkins, senior director of channel partnerships at Acquia, says Acquia is being used in Australia by Energy Australia, Flight Centre, Brisbane Airport Corporation and the Australian Government.
“We’ve been working hard to establish the Acquia brand and grow the Drupal community, through a strong partner channel in Asia Pacific and Japan, so to see the innovation taking place in a company as large and respected as Astellas Pharma, driven by CI&T, is more than encouraging, it’s exciting,” Watkins said.